Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Willow Grove, PA
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Clinical Research Facility
mi
from
Nashville, TN
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated:  7/24/2015
Research site
mi
from
Blagoevgrad,
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)
A Phase II, Randomized, Multi-center, Parallel-group, Rater-blinded Study to Evaluate the Efficacy, Safety and Tolerability of 0.5 mg, 3 mg, 10 mg and 20 mg Plovamer Acetate Doses Compared to Copaxone in Patients With Relapsing Remitting Multiple Sclerosis
Status: Enrolling
Updated: 7/24/2015
Research site
mi
from
Blagoevgrad,
Click here to add this to my saved trials
Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke
Use of a Wakefulness-Promoting Agent (Armodafinil) Combined With Neuro-rehabilitation to Improve Neurological Recovery and to Reduce the Incidence of Disability in Patients Who Suffered a Stroke
Status: Enrolling
Updated:  7/25/2015
The Burke Rehabilitation Hospital
mi
from
White Plains, NY
Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke
Use of a Wakefulness-Promoting Agent (Armodafinil) Combined With Neuro-rehabilitation to Improve Neurological Recovery and to Reduce the Incidence of Disability in Patients Who Suffered a Stroke
Status: Enrolling
Updated: 7/25/2015
The Burke Rehabilitation Hospital
mi
from
White Plains, NY
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Polytrauma Rehabilitation Center
mi
from
Palo Alto, CA
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Polytrauma Rehabilitation Center
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Craig Hospital
mi
from
Englewood, CO
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Craig Hospital
mi
from
Englewood, CO
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Rehabilitation Hospital of Indiana
mi
from
Indianapolis, IN
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Rehabilitation Hospital of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Rehabilitation Institute of Michigan
mi
from
Detroit, MI
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Rehabilitation Institute of Michigan
mi
from
Detroit, MI
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Hunter Holmes McGuire Medical Center
mi
from
Richmond, VA
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Hunter Holmes McGuire Medical Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated:  7/27/2015
Univ of Washington
mi
from
Seattle, WA
Treatment of Social Competence After Traumatic Brain Injury
Treatment of Social Competence in Military Veterans, Service Members, and Civilians With Traumatic Brain Injury
Status: Enrolling
Updated: 7/27/2015
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
University of California-Davis
mi
from
Sacramento, CA
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Children's National Health System
mi
from
Washington,
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Children's National Health System
mi
from
Washington,
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Johns Hopkins University School of Medicine, Kennedy Krieger
mi
from
Baltimore, MD
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Johns Hopkins University School of Medicine, Kennedy Krieger
mi
from
Baltimore, MD
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Carolinas Medical Center
mi
from
Charlotte, NC
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Duke Children's Hospital and Health Center
mi
from
Durham, NC
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Duke Children's Hospital and Health Center
mi
from
Durham, NC
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
University of Tennessee
mi
from
Memphis, TN
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
University of Tennessee
mi
from
Memphis, TN
Click here to add this to my saved trials
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated:  7/27/2015
Alberta Children's Hospital
mi
from
Calgary,
Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping
Status: Enrolling
Updated: 7/27/2015
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study
Status: Enrolling
Updated:  7/27/2015
Carolina NeuroSurgery & Spine Associates
mi
from
Charlotte, NC
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
Substance P Neuropeptide Levels in Saliva, Serum and Cerebrospinal Fluid in Patients With Spinal Disease: A Pilot Study
Status: Enrolling
Updated: 7/27/2015
Carolina NeuroSurgery & Spine Associates
mi
from
Charlotte, NC
Click here to add this to my saved trials
Virtual Reality Based Testing of Power Wheelchair Driving Skills
Computer-based and Virtual Assessment of Power Wheelchair Mobility
Status: Enrolling
Updated:  7/28/2015
VA Pittsburgh Health Care System
mi
from
Pittsburgh, PA
Virtual Reality Based Testing of Power Wheelchair Driving Skills
Computer-based and Virtual Assessment of Power Wheelchair Mobility
Status: Enrolling
Updated: 7/28/2015
VA Pittsburgh Health Care System
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluating the Effectiveness of a Handbook for Parents of Children Newly Diagnosed With Food Allergy
Living Confidently With Food Allergy: Evaluating the Effectiveness of a Handbook for the Newly Diagnosed
Status: Enrolling
Updated:  7/28/2015
Boston Children's Hospital
mi
from
Boston, MA
Evaluating the Effectiveness of a Handbook for Parents of Children Newly Diagnosed With Food Allergy
Living Confidently With Food Allergy: Evaluating the Effectiveness of a Handbook for the Newly Diagnosed
Status: Enrolling
Updated: 7/28/2015
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated:  7/28/2015
Child Psychopharmacology Institute
mi
from
Fargo, ND
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated: 7/28/2015
Child Psychopharmacology Institute
mi
from
Fargo, ND
Click here to add this to my saved trials
Medication Adherence in Individuals With Epilepsy
Best Practices and Challenges in Medication Adherence for Individuals With Epilepsy
Status: Enrolling
Updated:  7/29/2015
Columbia University Morningside Campus
mi
from
New York, NY
Medication Adherence in Individuals With Epilepsy
Best Practices and Challenges in Medication Adherence for Individuals With Epilepsy
Status: Enrolling
Updated: 7/29/2015
Columbia University Morningside Campus
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated:  7/29/2015
Baylor Institute for Rehabilitation
mi
from
Dallas, TX
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated: 7/29/2015
Baylor Institute for Rehabilitation
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated:  7/29/2015
Baylor Institute for Rehabilitation - Frisco
mi
from
Frisco, TX
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated: 7/29/2015
Baylor Institute for Rehabilitation - Frisco
mi
from
Frisco, TX
Click here to add this to my saved trials
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated:  7/29/2015
Baylor All Saints
mi
from
Ft. Worth, TX
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated: 7/29/2015
Baylor All Saints
mi
from
Ft. Worth, TX
Click here to add this to my saved trials
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated:  7/29/2015
Baylor Medical Center at Irving
mi
from
Irving, TX
Evaluation of Physical Therapy Interventions and Patient Characteristics on Outcomes
Evaluation of Physical Therapy Interventions and Patient Characteristics on Functional Mobility Outcomes in Persons With Acute Stroke
Status: Enrolling
Updated: 7/29/2015
Baylor Medical Center at Irving
mi
from
Irving, TX
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
Yale University
mi
from
New Haven, CT
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis
Motor Control Enhancement Through Repetitive Transcranial Magnetic Stimulation Plus Rehabilitation in Hemiparetic Cerebral Palsy and Stroke
Status: Enrolling
Updated:  7/30/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis
Motor Control Enhancement Through Repetitive Transcranial Magnetic Stimulation Plus Rehabilitation in Hemiparetic Cerebral Palsy and Stroke
Status: Enrolling
Updated: 7/30/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Mayo Clinic Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
Mayo Clinic
mi
from
Jacksonville, FL
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Wichita
mi
from
Wichita, KA
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Duluth
mi
from
Duluth, MN
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
Medcenter One Health System
mi
from
Bismarck, ND
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
Altru Cancer Center
mi
from
Grand Forks, ND
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
Altru Cancer Center
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Toledo Community Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated:  7/30/2015
CCOP - Oklahoma
mi
from
Tulsa, OK
Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
The Efficacy Of Gabapentin In The Management Of Chemotherapy-Induced Peripheral Neuropathy: A Phase III Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Status: Enrolling
Updated: 7/30/2015
CCOP - Oklahoma
mi
from
Tulsa, OK
Click here to add this to my saved trials